| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.081 | 0.3 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |